Bathi sadurunge mbayar bunga, pajak, lan amortisasi: markertherapeutics.com (MRKR)

Marker Therapeutics aims to reduce the production costs of lymphoma therapies, although the clinical trial stage requires colossal expenditures. The absolute operating profit on this chart resolves this dissonance, where the parameter value reaches 0.00, confirming high cash flow volatility. Ultimately, large-scale R&D investments in non-engineered MultiTAA cell products strengthen the company's scientific potential in the fight against blood cancer.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi Marker Therapeutics, Inc. (MRKR): kanggo periode 23.11.2025 - 14.11.2026

Ringkesan rincian data analitis Marker Therapeutics (MRKR)

- rega saham lan target rega konsensus:

Bagan rega Marker Therapeutics|MRKR - Bagan rega target

- indikator kapitalisasi bursa perusahaan:

Nilai pasar Marker Therapeutics Inc|MRKR - Nilai Total Perusahaan

- rincian valuasi buku bisnis:

Nilai Aset Bersih saben Saham Marker Therapeutics|MRKR - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku markertherapeutics.com|MRKR - Total Aset Perusahaan

- data tingkat utang lan likuiditas finansial:

Rasio Utang marang Ekuitas Marker Therapeutics|MRKR - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Marker Bio|MRKR - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Marker Therapeutics Inc|MRKR - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Marker Therapeutics|Rasio cepet markertherapeutics.com

- rincian bathi lan kelipatan pasar:

MRKR - Bathi resik|Bathi resik sing dikarepake Marker Therapeutics|MRKR - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi markertherapeutics.com|MRKR - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Marker Bio|MRKR - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone patang kuartal pungkasan Marker Therapeutics|MRKR - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan markertherapeutics.com|MRKR - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Marker Therapeutics

- data dodolan lan asil:

MRKR - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan Marker Bio|MRKR - Multiplikator P/S|Multiplikator Forward P/S Marker Therapeutics Inc

Ringkesan analitik perusahaan:MRKR (Marker Therapeutics, Inc.)

This indicator captures the actual cash flow from core operations before taxes and depreciation, allowing investors to assess the business's operational efficiency in real time. Analyzing the EBITDA chart is critical for Marker Therapeutics (MRKR), as it reflects the company's financial stability during the development of affordable cell therapy methods to combat hematological malignancies.

Pesaing Marker Therapeutics (MRKR)